Rapport Therapeutics (RAPP) CEO Ceesay Abraham Sells 18,921 Shares

What Happened
Ceesay Abraham, CEO of Rapport Therapeutics (RAPP), disposed of 18,921 shares on August 25, 2026 in an open-market sale for a total reported value of $937,957. The weighted-average price reported was $49.57; individual sale prices ranged from $49.03 to $50.03. The trade was reported as a sale (transaction code S).

Key Details

• Transaction date: 2026-08-25; Form 4 filed: 2026-08-26 (timely filing).
• Shares sold: 18,921; weighted-average price: $49.57; total proceeds: $937,957.
• Price range: $49.03 to $50.03 across multiple trades (per footnote); Reporting Person can provide per-price breakdown on request.
• Footnote: Sale was effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2026.
• Shares owned after transaction: Not disclosed in the provided excerpt.

Context
Sales executed under a pre-established 10b5-1 plan are typically scheduled in advance and are considered routine disclosures rather than a direct signal of the insider’s current view of the company. This filing reports a completed sale, not an option exercise, gift, or award.